Literature DB >> 6644563

Antitumor agents LXII: synthesis and biological evaluation of podophyllotoxin esters and related derivatives.

R K Levy, I H Hall, K H Lee.   

Abstract

Synthetic esters of the C-4 hydroxyl group of podophyllotoxin (I) were prepared. In addition, esters were synthesized using the diol system of tetrahydropyranyl podophyllol (XV), produced by reducing the lactone ring of tetrahydropyranyl podophyllotoxin with lithium aluminum hydride. Six compounds, the acrylate (IV), 3,3-dimethyl acrylate (V), phenoxyacetate (IX), and ethyl adipate (XI) of I as well as podophyllol (XIV) and tetrahydropyranyl podophyllol dimesylate (XVIII), showed significant activity when tested using the P-388 lymphocytic leukemia screen at 3 mg/kg/day. None of the esters showed higher activity than that shown by the parent molecule I when tested at the same dosage level.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6644563     DOI: 10.1002/jps.2600721012

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  4 in total

1.  A highly tumor-targeted nanoparticle of podophyllotoxin penetrated tumor core and regressed multidrug resistant tumors.

Authors:  Aniruddha Roy; Mark J Ernsting; Elijus Undzys; Shyh-Dar Li
Journal:  Biomaterials       Date:  2015-03-03       Impact factor: 12.479

2.  Synthesis, spectroscopic, and biological studies of novel estolides derived from anticancer active 4-O-podophyllotoxinyl 12-hydroxyl-octadec-Z-9-enoate.

Authors:  Jamal Mustafa; Shabana I Khan; Guoyi Ma; Larry A Walker; Ikhlas A Khan
Journal:  Lipids       Date:  2004-07       Impact factor: 1.880

3.  Synthesis and anticancer activities of fatty acid analogs of podophyllotoxin.

Authors:  Jamal Mustafa; Shabana I Khan; Guoyi Ma; Larry A Walker; Ikhlas A Khan
Journal:  Lipids       Date:  2004-02       Impact factor: 1.880

Review 4.  Recent progress on C-4-modified podophyllotoxin analogs as potent antitumor agents.

Authors:  Ying-Qian Liu; Jing Tian; Keduo Qian; Xiao-Bo Zhao; Susan L Morris-Natschke; Liu Yang; Xiang Nan; Xuan Tian; Kuo-Hsiung Lee
Journal:  Med Res Rev       Date:  2014-05-14       Impact factor: 12.944

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.